Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
As clinical trials progress and regulatory approvals are sought, these therapies have the potential to redefine obesity management and improve patient outcomes worldwide
These reduce the production of stomach acid
Increased Energy Expenditure The glucagon component may help increase calorie burning and fat metabolism
Clinical trials, including Phase 1 and Phase 2, have demonstrated Retatrutides substantial efficacy in weight reduction, with participants losing up to 24.2% of their starting body weight over 48 weeks, alongside improvements in glycemic control and lipid profiles
Take our quiz Answer a few quick questions so we can match you with the right treatment plan based on your goals and medical history
